title: Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
authors.affiliation: Rouen University Hospital and University of Rouen, Department of Neurology, 76031 Rouen cedex, France. Electronic address: romain.lefaucheur@chu-rouen.fr.
authors.forename: Romain
authors.initials: R
authors.lastname: Lefaucheur
authors.affiliation: Rouen University Hospital and University of Rouen, Department of Neurology, 76031 Rouen cedex, France.
authors.forename: Floriane
authors.initials: F
authors.lastname: Le Goff
authors.affiliation: Rouen University Hospital and University of Rouen, Department of Pharmacology, Rouen, France.
authors.forename: Gaëlle
authors.initials: G
authors.lastname: Gaillon
authors.affiliation: Rouen University Hospital and University of Rouen, Department of Neurology, 76031 Rouen cedex, France.
authors.forename: Aude
authors.initials: A
authors.lastname: Triquenot-Bagan
authors.affiliation: Rouen University Hospital and University of Rouen, Department of Neurology, 76031 Rouen cedex, France; Inserm U1079, Rouen Faculty of Medicine, Rouen, France.
authors.forename: David
authors.initials: D
authors.lastname: Maltête
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001711:Biotransformation; D004244:Dizziness / Q000139:chemically induced*; D004347:Drug Interactions; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D065427:Factor Xa Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D000069552:Rivaroxaban / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D014282:Trihexyphenidyl / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000978:Antiparkinson Agents; D065427:Factor Xa Inhibitors; D007189:Indans; C031967:rasagiline; D014859:Warfarin; D014282:Trihexyphenidyl; D000069552:Rivaroxaban